AC Immune SA (ACIU)
AC Immune SA is a Swiss biopharmaceutical company focused on developing therapies for neurodegenerative and age-related diseases, including Alzheimer's and Parkinson's. It specializes in innovative platforms such as antibody and vaccine development to target misfolded proteins associated with these conditions.
Company News
AC Immune is reducing workforce by 30% to focus on late-stage clinical development of neurodegenerative disease therapies, extending cash runway to Q3 2027 and maintaining key clinical milestones.
Biogen, Eli Lilly's, Prothena and AC Immune are included in this Analyst Blog.
The FDA has granted a Fast Track Designation to its Alzheimer's disease vaccine candidate.
Use these tips to trade penny stocks when you have limited capital The post Trading Penny Stocks With Limited Capital: 3 Tops Tips appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) shares jumped 105% to $0.2050 after the company signed a distribution agreement with Cardinal Health. Black Diamond Therapeutics, Inc. (NASDAQ: BDTX) surged 76.3% to $3.2450 after the company announced initial dose escalation data demonstrated anti-tumor activity of BDTX-1535 in non-small cell lu...